AstraZeneca Global Media site
AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing. Our priorities are to ensure the continued supply of our medicines to patients, and to safeguard the health and wellbeing of all our employees and communities.
AstraZeneca Australia is part of the global science-led biopharmaceutical company, AstraZeneca. We are engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians.
We focus on three main therapeutic areas; Oncology; Respiratory, Inflammation and Autoimmunity (RIA); Cardiovascular and Metabolic Diseases (CVMD). We build our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia, we have been working to deliver the best value to patients for more than 50 years, and our vision is to make the most meaningful difference to the lives of Australian patients ensuring Australians have access to our innovative medicines. We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.
Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.
We are focused on returning to growth through science-led innovation
We are focusing our science on our main therapy areas and accelerating our pipeline. We are also transforming our way of working.
We are focusing on our growth platforms and transforming the business through specialty care, devices and biologics. Targeted business development reinforces our efforts.
We are evolving our culture and simplifying our business. We want to attract and retain the best talent.